{"nct_id":"NCT05021536","title":"Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-08","start_date":"2021-10-28","start_date_type":"ACTUAL","primary_completion_date":"2024-01-19","primary_completion_date_type":"ACTUAL","completion_date":"2026-01-01","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AMLX"]}